KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Mon Feb 10, 2025 3:30 pm JST Earnings

4967 KOBAYASHI PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KOBAYASHI PHARMACEUTICAL CO.,LTD. <4967> [TSE Prime] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 decreased 1.7% from the previous period to 26.8 billion yen. In the fiscal year ending December 2025, the profit is expected to drop by 43.0% from the previous period to 15.3 billion yen. This will be the third consecutive term of declining profits.

At the same time, the company has decided to increase the dividend this fiscal year to 104 yen, an increase of 2 yen from the previous fiscal year.

In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit increased 37.7% from the same period last year, reaching 8.94 billion yen. The operating profit margin jumped from 11.8% in the same period last year to 15.4%.

Kabutan News

Actual Results

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	166,258	26,669	28,281	20,022	259.6	90	Feb 14, 2023	J-GAAP
Dec, 2023	173,455	25,780	27,330	20,338	268.2	101	Feb 9, 2024	J-GAAP
Dec, 2024	165,600	24,860	26,861	10,067	135.4	102	Feb 10, 2025	J-GAAP
YoY	-4.5%	-3.6%	-1.7%	-50.5%	-49.5%

Full Year Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2024 Guidance	169,000	24,000	25,500	10,700	143.9	102	Nov 8, 2024	J-GAAP
Dec, 2024 Results	165,600	24,860	26,861	10,067	135.4	102	Feb 10, 2025	J-GAAP
Revision Rate	-2.0%	+3.6%	+5.3%	-5.9%	-5.9%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2024	73,136	9,471	10,434	1,436	19.3	43	Aug 8, 2024	J-GAAP
Jan - Jun, 2025 Guidance	ー	ー	ー	ー	－	44	Feb 10, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	173,455	25,780	27,330	20,338	268.2	101	Feb 9, 2024	J-GAAP
Dec, 2024	165,600	24,860	26,861	10,067	135.4	102	Feb 10, 2025	J-GAAP
Dec, 2025 Guidance	171,000	14,000	15,300	10,500	141.3	104	Feb 10, 2025	J-GAAP
YoY	+3.3%	-43.7%	-43.0%	+4.3%	+4.3%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	54,340	6,393	6,493	4,840	63.8	11.8	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	36,485	5,028	5,461	976	13.1	13.8	May 10, 2024	J-GAAP
Apr - Jun, 2024	36,651	4,443	4,973	460	6.2	12.1	Aug 8, 2024	J-GAAP
Jul - Sep, 2024	41,323	7,505	7,487	3,908	52.6	18.2	Nov 8, 2024	J-GAAP
Oct - Dec, 2024	51,141	7,884	8,940	4,723	63.5	15.4	Feb 10, 2025	J-GAAP
YoY	-5.9%	+23.3%	+37.7%	-2.4%	-0.5%